HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chemokine CCL24

A CC-type chemokine with specificity for CCR3 RECEPTORS. It is a chemoattractant for EOSINOPHILS.
Also Known As:
Eotaxin-2; Myeloid Progenitor Inhibitory Factor 2; CCL24, Chemokine; Chemokine, CCL24; Eotaxin 2; CCL24 Chemokine
Networked: 86 relevant articles (4 outcomes, 14 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Rothenberg, Marc E: 6 articles (07/2010 - 11/2003)
2. Lee, James J: 3 articles (12/2013 - 06/2007)
3. Fulkerson, Patricia C: 3 articles (07/2010 - 04/2005)
4. Blanchard, Carine: 3 articles (07/2010 - 04/2005)
5. Hogan, Simon P: 3 articles (11/2008 - 11/2003)
6. Zimmermann, Nives: 3 articles (10/2005 - 11/2003)
7. Park, Young-Ran: 3 articles (03/2005 - 07/2004)
8. Chung, Hun-Taeg: 3 articles (03/2005 - 07/2004)
9. Chae, Soo-Cheon: 3 articles (03/2005 - 07/2004)
10. Lee, Young-Cheol: 2 articles (12/2015 - 03/2009)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Inflammation
3. Hypersensitivity (Allergy)
09/01/2002 - "Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers."
10/01/2004 - "Eotaxin, eotaxin-2, and eotaxin-3 are important chemoattractants for eosinophils, and these chemokines are expressed during different phases of the allergic reaction. "
02/01/2000 - "The beta-chemokine receptor CCR3, which recognizes the ligands eotaxin, eotaxin-2, monocyte chemotactic protein (MCP) 3, MCP4, and RANTES, plays a central role in this process, and antagonists to this receptor could have potential therapeutic use in the treatment of allergy. "
10/01/1999 - "The relationship of expression of the C-C chemokines eotaxin, eotaxin 2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4 to the kinetics of infiltrating eosinophils, basophils, and other inflammatory cells was examined in allergen-induced, late-phase allergic reactions in the skin of human atopic subjects. "
10/01/2004 - "Research developments in ocular allergy summarized in this article include the following findings: (1) ocular epithelial cells play a role in inflammation; (2) respiratory syncytial virus is a pathogen in allergic conjunctivitis; (3) transglutaminase inhibitors reverse allergic related inflammation; (4) eosinophils and neutrophils both play a role in ocular allergy; (5) eotaxin-1 and eotaxin-2 play a role in eosinophilic recruitment; and (6) loteprednol etabonate, desonide phosphate, and cyclosporine have been shown to be effective and safe in the treatment of ocular allergy. "
4. Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Chemokine CCL11
2. Cytokines
3. Interleukin-5 (Interleukin 5)
4. Interleukin-4 (Interleukin 4)
5. Messenger RNA (mRNA)
6. Interleukin-13
7. Chemokine CCL17
8. Ovalbumin
9. Immunoglobulin E (IgE)
10. Adrenal Cortex Hormones (Corticosteroids)

Related Therapies and Procedures

1. Coronary Artery Bypass (Coronary Artery Bypass Surgery)